SIHUAN PHARM Publishes FY2025 Annual Report and ESG Report

Bulletin Express04-27

SIHUAN PHARM disclosed that both the English and Chinese versions of its FY2025 Annual Report and the ESG Report 2025 are now available on the company website (www.sihuanpharm.com) and on HKExnews (www.hkexnews.hk).

Non-registered shareholders can download the documents under the “Investor Relations—Financial Statements/ESG Information” section. Those preferring hard copies may submit a request to the share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.

For future corporate communications, the company will send electronic or postal notices on the publication date if a functional e-mail or postal address is on file. Shareholders who have not provided such contact details will not receive separate publication notices.

The notification reaffirms that shareholders may at any time instruct the registrar on their preferred language (English, Chinese, or both) and format (electronic or printed) for all subsequent corporate communications.

Chairman and Executive Director Dr. Che Fengsheng signed the notice on 28 April 2026 on behalf of the Board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment